Pure Global AI
ANVISA registration 81285200021Valid until Jan 27, 2035

TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)

ANVISA Registration Number: 81285200021FUNDAÇÃO BAIANA DE PESQ. CIENTIFICA E DESENV. TECNOLOGICO, FORNECIMENTO E DISTRIBUIÇÃO DE MEDICAMENTOS-BAHIAFARMABEIJING HOTGEN BIOTECH CO., LTD.Risk Class IV
Device names
Technical name
TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)
PT: ANTICORPO TOTAL PARA VÍRUS DE HEPATITE C (ANTI-HCV)
Commercial name
Teste Rápido Anti-HCV Bahiafarma (Ouro Coloidal)
Risk class
Class IV
Registration details
Registration Number
81285200021
Process Number
25351310889202467
CNPJ
13078518000190
Company information
Manufacturing Country
China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
Publication Date
Jan 27, 2025
Validity
27/01/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81285200021 and manufactured by BEIJING HOTGEN BIOTECH CO., LTD.. The registration is held by FUNDAÇÃO BAIANA DE PESQ. CIENTIFICA E DESENV. TECNOLOGICO, FORNECIMENTO E DISTRIBUIÇÃO DE MEDICAMENTOS-BAHIAFARMA with validity until Jan 27, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.